Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Polypeptide capable of inhibiting novel coronavirus and application for polypeptide

A coronavirus, a new type of technology, applied in the direction of viral peptides, viruses, antiviral agents, etc., can solve problems such as difficulties in virus prevention and control, and there is no preventive vaccine, and achieve the effect of inhibiting and controlling infection

Active Publication Date: 2020-06-30
北京中科微盾生物科技有限责任公司
View PDF8 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above characteristics have caused great difficulties for the prevention and control of the virus
There is currently no preventive vaccine and effective treatment for the virus

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polypeptide capable of inhibiting novel coronavirus and application for polypeptide
  • Polypeptide capable of inhibiting novel coronavirus and application for polypeptide
  • Polypeptide capable of inhibiting novel coronavirus and application for polypeptide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] In this example, Hun-7 cells and 293T cells were used to conduct an experiment on the inhibitory effect of the polypeptide 2019-nCov-P1 on the new coronavirus, which specifically included the following steps:

[0039] 1. Fake virus packaging

[0040] 1.1 Plasmid extraction

[0041] Pseudovirus system plasmid construction, the full-length 2019-nCov S protein was constructed into the PSV multiple cloning site, and the backbone plasmid pNL-LUR-E- was simultaneously transformed into DH5-a competent cells; 42 degrees Celsius, heat shock for 90 seconds Afterwards, spread the LB plate, the concentration of ampicillin is 5 micrograms per milliliter; cultivate overnight in a 37 degree incubator.

[0042] Pick a single colony and inoculate LB liquid medium with an ampicillin concentration of 5 micrograms per milliliter. Shake the bacteria overnight at 37°C.

[0043] Centrifuge at 12000 for 10 minutes, collect the bacteria, and extract the plasmid with Tiangen Plasmid Extractio...

Embodiment 2

[0062] The difference between this example and Example 1 is that the polypeptide 2019-nCov-P1 is replaced by the polypeptide 2019-nCov-P2.

[0063] The inhibitory efficiency of 2019-nCov-P2 on the new coronavirus is as follows: figure 2 shown.

Embodiment 3

[0065] Elisa detection of peptide binding to HR2

[0066] The HR2 polypeptide was coated onto a 96-well plate. The method is as follows, go to the polystyrene Elisa plate to equilibrate at room temperature. Dilute the HR2 polypeptide with the coating solution to a final concentration of 0.1 microgram per microliter. Coating liquid composition: 0.1696 g of anhydrous sodium carbonate, 0.2856 g of sodium bicarbonate, dissolved in 100 ml of deionized water, and added with a final concentration of 1% SDS. Add 100 microliters of protein dilution to each well. overnight at 4°C. Discard the coating solution, wash with PBST, add 300 microliters to each well, let it stand for 10 minutes, discard the washing solution, fill up the washing solution, repeat 5 times, and drain the washing solution. Washing liquid PBST: 8 grams of sodium chloride, 2.9 grams of disodium hydrogen phosphate 12 hydrate, 0.2 grams of potassium chloride, 0.24 grams of potassium dihydrogen phosphate, 0.5 millili...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a polypeptide capable of inhibiting novel coronavirus, belonging to the field of biological medicines. The polypeptide is 2019-nCov-P1 or 2019-nCov-P2 which respectively have anamino acid sequence as shown in SEQ ID NO: 1 or SEQ ID NO: 2. The polypeptide can be specifically combined with an S protein HR2 region of COVID-19, so the combination of viruses and cells is blocked, and the virus infection is effectively inhibited and controlled. The invention also provides an application of the polypeptide in preparation of a medicine for preventing and / or treating COVID-19.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to a novel coronavirus invasion-inhibiting polypeptide, in particular to the application of the polypeptide and its derivatives in the preparation of drugs for the prevention and / or treatment of COVID-19. Background technique [0002] Research shows that COVID-19 is a new type of coronavirus that uses the same cell receptor ACE-2 as the SARS virus, and the virus persists in the environment for a long time. Compared with the SARS virus, the transmission of COVID-19 is more stealthy, with various transmission routes and a longer incubation period. The above-mentioned characteristics have caused great difficulties for the prevention and control of the virus. Currently there is no preventive vaccine and effective treatment for this virus. Therefore, effective prevention methods and treatment measures for this virus need to be developed urgently. Contents of the invention [0003] In order t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/165A61K38/16A61P31/14
CPCA61K38/00A61P31/14C07K14/005C12N2770/20022C12N2770/20033
Inventor 岳少恒任金成
Owner 北京中科微盾生物科技有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com